Carrie Lee, MD, MPH, medical director of UNC Lineberger’s Clinical Protocol Office, has been appointed the chair-elect of the Association of American Cancer Institute’s Clinical Research Initiative Steering Committee. Her chair term will start in 2017.
Lee, who is an assistant professor in the Division of Hematology/Oncology, oversees clinical, regulatory, compliance, financial and data management for the therapeutic clinical trials at UNC Lineberger.
AACI established the Clinical Research Initiative eight years ago to pursue a variety of objectives, including developing better methods to disseminate information across cancer centers, identifying and addressing clinical research challenges, and measuring progress.
Lee said she is honored to serve in this capacity. "The scientific advances driving the era of personalized cancer medicine are tremendous," Lee noted. ":But we need to take an equally intense look at the clinical trial processes and operations that will facilitate enrollment of patients on the innovative trials that will bring these new treatments from bench to bedside—if we don’t do that, we’ve missed the boat. My role as chair-elect of the AACI-CRI steering committee gives UNC Lineberger an opportunity to have a voice in bringing these two fronts together—the science and the operations—to ultimately improve and extend the lives of cancer patients."
AACI was founded to reduce the burden of cancer by enhancing the impact of the leading academic cancer centers in the U.S. and Canada. AACI facilitates interaction among its 95 member centers, educates policy makers, and fosters the development of partnerships between cancer centers and other cancer organizations to improve the overall quality of cancer care.
As part of its mission, AACI gathers and shares best practices among cancer centers, providing a forum for its members to address common challenges and explore new opportunities, supporting initiatives that engage the membership in developing specific recommendations to the National Cancer Institute, and educating policy makers about the important role cancer centers play in advancing cancer discovery.